Asuragen Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
99
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$321M
Asuragen General Information
Description
Manufacturer of molecular diagnostic products designed to optimize patient management in oncology and genetic diseases. The company offers a wide range of kits and assays for genetic sequencing as well as cancer monitoring, enabling the medical community to enhance treatment outcomes through accurate data.
Contact Information
Website
www.asuragen.com(Operating Subsidiary)
Corporate Office
- 2150 Woodward Street
- Suite 100
- Austin, TX 78744
- United States
Corporate Office
- 2150 Woodward Street
- Suite 100
- Austin, TX 78744
- United States
Asuragen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 06-Apr-2021 | $321M | Completed | Generating Revenue | ||
| 6. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 20-Mar-2013 | Completed | Generating Revenue | |||
| 4. Grant | 30-Mar-2012 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 11-Aug-2011 | Completed | Generating Revenue | |||
| 2. Grant | 08-Oct-2008 | $3.8M | $18.5M | Completed | Startup | |
| 1. Early Stage VC (Series B) | 10-Dec-2007 | $18.5M | $18.5M | Completed | Startup |
Asuragen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 48,895,000 | $0.001000 | $1 | $1 | 1x | $1 | 56.29% |
Asuragen Comparisons
Industry
Financing
Details
Asuragen Competitors (13)
One of Asuragen’s 13 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Bio-Techne | Corporation | Minneapolis, MN | ||||
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| Admera Health | Venture Capital-Backed | South Plainfield, NJ |
Asuragen Patents
Asuragen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210189384-A1 | Methods and compositions for amplicon concatenation | Inactive | 26-Nov-2019 | ||
| US-11236384-B2 | Methods of rna amplification | Active | 19-Jan-2017 | ||
| US-12139755-B2 | Methods of rna amplification | Active | 19-Jan-2017 | ||
| US-20200140923-A1 | Methods of rna amplification | Active | 19-Jan-2017 | ||
| US-20220177949-A1 | Methods of rna amplification | Active | 19-Jan-2017 | C12Q1/686 |
Asuragen Signals
Asuragen Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cancer Prevention and Research Institute of Texas | Government | |||
| Growth Capital Fund | Venture Capital | Minority | ||
| MSD Global Health Innovation Fund | Corporate Venture Capital | Minority | ||
| PTV Healthcare Capital | Venture Capital | Minority | ||
| Southwest Middle Market M&A | Merchant Banking Firm | Minority |
Asuragen Investments (2)
Asuragen’s most recent deal was a Early Stage VC with Mirna Therapeutics for . The deal was made on 01-Jan-2009.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mirna Therapeutics | 01-Jan-2009 | Early Stage VC | Biotechnology | ||
| Mirna Therapeutics | 04-Apr-2008 | Seed Round | Biotechnology |
Asuragen FAQs
-
When was Asuragen founded?
Asuragen was founded in 2005.
-
Where is Asuragen headquartered?
Asuragen is headquartered in Austin, TX.
-
What is the size of Asuragen?
Asuragen has 99 total employees.
-
What industry is Asuragen in?
Asuragen’s primary industry is Diagnostic Equipment.
-
Is Asuragen a private or public company?
Asuragen is a Private company.
-
What is the current valuation of Asuragen?
The current valuation of Asuragen is .
-
What is Asuragen’s current revenue?
The current revenue for Asuragen is .
-
How much funding has Asuragen raised over time?
Asuragen has raised $31M.
-
Who are Asuragen’s investors?
Cancer Prevention and Research Institute of Texas, Growth Capital Fund, MSD Global Health Innovation Fund, PTV Healthcare Capital, and Southwest Middle Market M&A are 5 of 7 investors who have invested in Asuragen.
-
Who are Asuragen’s competitors?
Foundation Medicine, Illumina, Bio-Techne, CIS Bio International, and Admera Health are some of the 13 competitors of Asuragen.
-
When was Asuragen acquired?
Asuragen was acquired on 06-Apr-2021.
-
Who acquired Asuragen?
Asuragen was acquired by Bio-Techne.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process